Andrew X. Zhang

15 papers receiving 671 citations

Peers

Andrew X. Zhang
Comparison fields: 5 of 64
  • Molecular Biology 462
  • Radiology, Nuclear Medicine and Imaging 252
  • Oncology 191
  • Organic Chemistry 101
  • Immunology 90
Replace Ben‐Fillippo Krippendorff with:
Ben‐Fillippo Krippendorff Switzerland
Alessandro Zorzi Switzerland
Victor Gonçalves France
Oliver Demmer Germany
Daniel J. Kroon United States
George K. Ehrlich United States
Daniel P. Teufel United Kingdom
Sílvia Barrabés Spain
Christian Tiede United Kingdom
Shauna West United Kingdom
Andrew X. Zhang relative to Ben‐Fillippo Krippendorff Switzerland Ben‐Fillippo Krippendorff's profile →
Citations per field
00.5×1.5×2.0×
Ben‐Fillippo Krippendorff · 1×
Citations per year

Countries citing papers authored by Andrew X. Zhang

Since Specialization
Citations

This map shows the geographic impact of Andrew X. Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew X. Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew X. Zhang more than expected).

Fields of papers citing papers by Andrew X. Zhang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew X. Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew X. Zhang. The network helps show where Andrew X. Zhang may publish in the future.

Co-authorship network of co-authors of Andrew X. Zhang

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew X. Zhang. A scholar is included among the top collaborators of Andrew X. Zhang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew X. Zhang. Andrew X. Zhang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
#WorkIndexed citations
1 2
2 8
3 0
4 3
5 14
6 4
7 10
8 158
9 64
10 6
11 1
12 36
13 118
14 24
15 131
16 101

About Andrew X. Zhang

Andrew X. Zhang is a scholar working on Radiology, Nuclear Medicine and Imaging, Organic Chemistry and Molecular Biology, having authored 16 papers that have together received 680 indexed citations. Recurring topics across this work include Protein Degradation and Inhibitors (6 papers), Click Chemistry and Applications (5 papers) and Ubiquitin and proteasome pathways (5 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (252 citations), Oncology (191 citations) and Molecular Biology (462 citations). Andrew X. Zhang has collaborated with scholars based in United States, Sweden and Germany. Frequent co-authors include David A. Spiegel, Patrick J. McEnaney, Julien Michel, William L. Jorgensen, Ryan P. Murelli, Christopher G. Parker, M. Paola Castaldi, Kévin Moreau, Fiona Pachl and Göran Dahl. Their work appears in journals such as Journal of the American Chemical Society, International Journal of Molecular Sciences and British Journal of Pharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026